Pharmaceutical formulation comprising levothyroxine sodium

Details for Australian Patent Application No. 2004255466 (hide)

Owner Glaxo Group Limited

Inventors Roman, Wanda; Strozyk, Malgorzata Anna; Krohn, Heiner; Schlehahn, Hendrik; Konieczna, Malgorzata

Agent Davies Collison Cave

Pub. Number AU-B-2004255466

PCT Pub. Number WO2005/004849

Priority 0316206.2 10.07.03 GB

Filing date 8 July 2004

Wipo publication date 20 January 2005

Acceptance publication date 26 July 2007

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/198 (2006.01)

Event Publications

19 January 2006 PCT application entered the National Phase

  PCT publication WO2005/004849 Priority application(s): WO2005/004849

26 July 2007 Application Accepted

  Published as AU-B-2004255466

22 November 2007 Standard Patent Sealed

29 October 2009 Assignment Registered

  Glaxo Group Limited The patent has been assigned to Aspen Global Incorporated

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255470-Packaged virus-like particles

2004255459-Pharmaceutical composition for solubility enhancement of hydrophobic drugs